Skip to main content

Axsome Therapeutics, Inc 10-K for FY2024

Axsome Therapeutics, Inc. (AXSM)

10-K 2025-02-18 For: 2024-12-31
View Original
Added on April 09, 2026

About this 10-K

Axsome Therapeutics, Inc filed this 10-K on February 18, 2025, covering the fiscal year ended December 31, 2024 (FY2024).

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$385.69M
up 42.5% from $270.6M a year earlier
Net loss
$287.22M
compared with a net loss of $239.24M a year earlier
Diluted EPS
-$5.99
compared with -$5.27 a year earlier